Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abandon, abolished, accessible, accomplish, Acrotech, addMelphalan, administered, administering, Admission, advanceVincristine, analyzing, ancillary, andtenofovir, andVincristine, AOCI, appoint, AQSIQ, asMelphalan, assembled, attend, background, big, binding, Biopharma, budget, built, buy, CAC, candidatesMelphalan, carryforward, central, centralized, chain, Chaoyang, chapter, Chi, choice, choose, CohnReznick, commercializingMelphalan, commonly, comparison, complement, compromise, conclusion, concurrently, Conference, confidence, construct, constructed, construction, content, convincing, counterfeit, counterpart, county, court, CRGK, CSRC, database, defend, demand, Department, deprived, desirable, detachable, deviating, disagreement, discretion, disoproxil, disposition, dissolution, distributor, District, Document, documentation, Door, downgrade, dramatic, dropping, easier, economy, efficient, endorsement, engineering, entecavir, exploratory, extraordinary, extremely, facilitate, facilityin, flow, foregoing, forMelphalan, forward, founder, fourth, frequency, fumarate, genuine, George, goal, grown, Guokang, halt, hematology, highest, hope, Huazhen, Huicun, Huishan, illegally, immaterial, inaccurate, inadequate, includingMelphalan, increasingly, India, Inspected, inspection, intangible, inventory, invited, Jiangsu, Jianguo, Jintou, joint, KPMG, Larry, Lastly, lawfully, leave, lie, LLP, massive, maximize, mechanism, Memorandum, message, minimally, missing, mix, municipal, narcotic, narrow, Navigating, NDRL, NHSA, NMPA, nonclinical, Nonemployee, NRDL, ofIbritumomab, ofMelphalan, orMelphalan, ourMelphalan, output, palliative, physician, pilot, policing, population, potent, proliferation, Province, provincial, psychotropic, publish, pure, purporting, Quarantine, RDL, readily, recoverability, recoverable, refocused, regularly, reject, rejection, reorganization, repeat, Republic, reshuffle, resubmit, retail, Road, robust, routine, SAC, SAIC, SAMR, Science, screen, sequential, shortage, social, society, speak, statistical, subgroup, substantive, succeed, sweeping, switch, symbol, TDF, tender, tenofovir, thatMelphalan, theWuxi, threshold, Tower, trend, Trump, unadjusted, understated, undertaken, undesirable, undiscounted, unfamiliar, uniform, unqualified, UntilMelphalan, USD, venture, volume, Wei, whenMelphalan, win, won, Wuxi, Zhang, Zone, Zonein
Removed:
aperformance, assured, awarded, begun, biomarker, Bioventure, borrowing, buyer, calling, cancelled, Careful, Celgene, CFDA, clearance, collectibility, competitor, copy, core, Corporation, corroborated, culture, Diligent, Dr, earned, eligible, eliminate, EMA, employ, encourage, entrepreneurialism, environment, European, eventual, exchanged, extend, federally, fewer, fixed, fluid, forfeited, forfeiture, Gate, HCC, hepatocellular, history, incremental, ineffective, infrequently, innovation, intensely, issuable, kft, lending, Likewise, maturity, mission, molecule, myeloid, nationally, nonqualified, notice, obligated, observable, orphan, outcome, outlined, ovarian, partially, periodically, persuasive, posted, preclude, priced, prudent, receivable, Red, regionally, Remeasurement, reportable, resource, restructured, retention, reversal, Room, setback, skilled, spending, Street, suffered, supplemental, suspended, thalidomide, thatperformance, toxic, tubulin, turnover, uneconomical, unsettled, vested, Vice, Web, withperformance, yielded, ZEVALIN®therapeutic
Filing tables
Filing exhibits
- 10-K Annual report
- 10.20 Exhibit 10.20
- 10.21 Exhibit 10.21
- 10.22 Exhibit 10.22
- 10.23 Exhibit 10.23
- 10.24 Exhibit 10.24
- 10.25 Exhibit 10.25
- 10.26 Exhibit 10.26
- 21 Exhibit 21
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
- 32.2 Exhibit 32.2
- Download Excel data file
- View Excel data file
Related press release
CASI similar filings
Filing view
External links
Exhibit 21
Subsidiaries of the Registrant
CASI Pharmaceuticals (Beijing) Co., Ltd. (also known as CASI (Beijing) Biopharmaceuticals Technology Co., Ltd.), a company of limited liability, incorporated and existing under the laws of the People’s Republic of China
Beijing Zhongbai Biotechnology Co., Ltd. (also known as Beijing Zhongbio Therapeutics, Ltd.), a company of limited liability, incorporated and existing under the laws of the People’s Republic of China
Miikana Therapeutics, Inc., incorporated in Delaware